Login to Your Account



Other News To Note


Wednesday, August 8, 2012
• Cell Cure Neurosciences Ltd., of Jerusalem, a subsidiary of BioTime Inc., received a grant of NIS5.04 million (US$1.33 million) from Israel's Office of the Chief Scientist for development of a cell-based therapeutic product for age-related macular degeneration.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription